rosiglitazone has been researched along with Brain Ischemia in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (29.41) | 29.6817 |
| 2010's | 12 (70.59) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cui, MM; Dai, CX; Ding, X; Fu, YY; Guo, MY; Li, M; Li, ZL; Qi, DS; Song, YJ; Wang, CL; Wang, YL; Wen, XR; Zhao, XF | 1 |
| Ballesteros, I; Corbí, A; Cuartero, MI; de la Parra, J; Hamilton, JA; Lizasoain, I; Moro, MA; Nombela, F; Pérez-Ruiz, A; Pradillo, JM; Ricote, M; Sobrado, M; Vivancos, J | 1 |
| Al Rouq, F; El Eter, E | 1 |
| Liu, ZJ; Shao, ZQ | 1 |
| Cai, W; Chen, J; Han, L; Hu, X; Leak, RK; Li, P; Liu, J; Mao, L; Xu, Y | 1 |
| Guo, F; Liu, L; Song, W; Wang, Q; Xiong, L; Yang, R; Zhong, H | 1 |
| Chen, JJ; Chen, YC; Chen, YE; Chen, YT; Cheung, WM; Fong, WH; Lin, TN; Liou, JY; Maeda, N; Shyue, SK; Tsai, HD; Tsai, YS; Wu, JS; Wu, KK | 1 |
| Allahtavakoli, M; Arababadi, MK; Javanmardi, K; Moloudi, R; Shamsizadeh, A | 1 |
| Ding, X; He, C; Noor, R; Pegg, C; Shuaib, A; Wang, CX | 1 |
| Chen, YC; Fong, WH; Lin, TN; Tsai, HD; Wu, JS | 1 |
| Ghabaei, M; Nategh, M; Parviz, M; Sadr, SSh; Shabanzadeh, AP; Shaveisi, K | 1 |
| Blankenship, DA; Gamboa, J; Hilow, E; Karl, M; Landreth, GE; Niemi, JP; Sundararajan, S | 1 |
| Cheng, FC; Cheng, SM; Chou, CC; Chuang, HC; Lee, MR; Sheu, WH | 1 |
| Haq, W; Katti, SB; Raghubir, R; Raza, S; Samuel, SS; Verma, R | 1 |
| Barut, F; Jakubowska-Dogru, E; Ozacmak, VH; Sayan-Ozacmak, H | 1 |
| Aragno, M; Collino, M; Danni, O; Dianzani, C; Fantozzi, R; Gallicchio, M; Mastrocola, R; Rosa, AC; Thiemermann, C | 1 |
| Chen, J; Graham, SH; Hong, Z; Luo, Y; Signore, AP; Wang, S; Yin, W; Zhang, F | 1 |
1 review(s) available for rosiglitazone and Brain Ischemia
| Article | Year |
|---|---|
Anti-apoptotic actions of PPAR-gamma against ischemic stroke.
Topics: 14-3-3 Proteins; Animals; Apoptosis; bcl-Associated Death Protein; Brain Ischemia; Humans; Hypoglycemic Agents; Ligands; PPAR gamma; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-bcl-2; Rosiglitazone; Stroke; Thiazolidinediones | 2010 |
16 other study(ies) available for rosiglitazone and Brain Ischemia
| Article | Year |
|---|---|
The potential role of HO-1 in regulating the MLK3-MKK7-JNK3 module scaffolded by JIP1 during cerebral ischemia/reperfusion in rats.
Topics: Adaptor Proteins, Signal Transducing; Animals; Brain Ischemia; CA1 Region, Hippocampal; Cell Death; Disease Models, Animal; Down-Regulation; Heme Oxygenase (Decyclizing); Male; MAP Kinase Kinase Kinases; Maze Learning; Mitogen-Activated Protein Kinase 10; Mitogen-Activated Protein Kinase Kinase Kinase 11; Mitogen-Activated Protein Kinases; Neurons; Neuroprotection; Neuroprotective Agents; Phosphorylation; Proto-Oncogene Proteins c-jun; Rats, Sprague-Dawley; Reperfusion Injury; Rosiglitazone | 2019 |
Rosiglitazone-induced CD36 up-regulation resolves inflammation by PPARγ and 5-LO-dependent pathways.
Topics: Animals; Arachidonate 5-Lipoxygenase; Brain Ischemia; CD36 Antigens; Cells, Cultured; Hypoglycemic Agents; Inflammation; Lipoxins; Mice; Mice, Inbred C57BL; Neutrophils; Phagocytosis; PPAR gamma; Rats; Rosiglitazone; Thiazolidinediones; Up-Regulation | 2014 |
PPAR-γ activator induces neuroprotection in hypercholesterolemic rats subjected to global cerebral ischemia/reperfusion injury: in vivo and in vitro inhibition of oxidative stress.
Topics: Animals; Brain Edema; Brain Ischemia; Dose-Response Relationship, Drug; Glutathione; Hypercholesterolemia; Interleukin-6; Lipid Peroxidation; Male; Neuroprotective Agents; Oxidative Stress; Peroxidase; PPAR gamma; Rats; Rats, Wistar; Reperfusion Injury; Rosiglitazone; Thiazolidinediones; Tumor Necrosis Factor-alpha | 2014 |
Neuroinflammation and neuronal autophagic death were suppressed via Rosiglitazone treatment: New evidence on neuroprotection in a rat model of global cerebral ischemia.
Topics: Animals; Autophagy; Brain Edema; Brain Ischemia; Cerebral Infarction; Disease Models, Animal; Female; Inflammation; Neurons; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Recovery of Function; Rosiglitazone; Thiazolidinediones | 2015 |
Rosiglitazone Promotes White Matter Integrity and Long-Term Functional Recovery After Focal Cerebral Ischemia.
Topics: Animals; Brain Ischemia; Disease Models, Animal; Infarction, Middle Cerebral Artery; Male; Mice; Mice, Inbred C57BL; Microglia; Oligodendroglia; PPAR gamma; Recovery of Function; Reperfusion; Rosiglitazone; Thiazolidinediones; White Matter | 2015 |
Therapeutic window of globular adiponectin against cerebral ischemia in diabetic mice: the role of dynamic alteration of adiponectin/adiponectin receptor expression.
Topics: Adiponectin; Animals; Apoptosis; Brain Ischemia; Caspase 12; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; eIF-2 Kinase; Endoplasmic Reticulum Chaperone BiP; Gene Expression Regulation; Heat-Shock Proteins; Humans; Hypoglycemic Agents; Injections, Intraventricular; Male; Membrane Proteins; Mice; Mice, Inbred C57BL; Neurons; Neuroprotective Agents; Protein Serine-Threonine Kinases; Receptors, Adiponectin; Reperfusion Injury; RNA, Small Interfering; Rosiglitazone; Signal Transduction; Thiazolidinediones; Transcription Factor CHOP | 2015 |
Ligand-activated peroxisome proliferator-activated receptor-gamma protects against ischemic cerebral infarction and neuronal apoptosis by 14-3-3 epsilon upregulation.
Topics: 14-3-3 Proteins; Animals; Apoptosis; Brain Ischemia; Cell Line, Tumor; Cerebral Infarction; Ligands; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Neurons; PPAR gamma; Rats; Rosiglitazone; Thiazolidinediones; Transcription, Genetic; Up-Regulation | 2009 |
Delayed post ischemic treatment with Rosiglitazone attenuates infarct volume, neurological deficits and neutrophilia after embolic stroke in rat.
Topics: Animals; Brain Infarction; Brain Ischemia; Cell Death; Disease Models, Animal; DNA Fragmentation; Encephalitis; Hypoglycemic Agents; Infarction, Middle Cerebral Artery; Leukocyte Count; Male; Neuroprotective Agents; Neutrophils; Rats; Rats, Wistar; Rosiglitazone; Thiazolidinediones; Time Factors; Treatment Outcome | 2009 |
Rosiglitazone alone or in combination with tissue plasminogen activator improves ischemic brain injury in an embolic model in rats.
Topics: Animals; Brain Ischemia; Collagen Type IV; Disease Models, Animal; Drug Therapy, Combination; Embolism; Hypoglycemic Agents; Matrix Metalloproteinase 9; Middle Cerebral Artery; Neuroprotective Agents; PPAR gamma; Rats; Rosiglitazone; Thiazolidinediones; Tissue Plasminogen Activator; Treatment Outcome | 2009 |
Systemic hyperthermia masks the neuroprotective effects of MK-801, but not rosiglitazone in brain ischaemia.
Topics: Animals; Brain Ischemia; Disease Models, Animal; Dizocilpine Maleate; Fever; Male; Neuroprotective Agents; Rats; Rats, Wistar; Rosiglitazone; Thiazolidinediones | 2010 |
Extension of the neuroprotective time window for thiazolidinediones in ischemic stroke is dependent on time of reperfusion.
Topics: Animals; Behavior, Animal; Blood Pressure; Brain; Brain Ischemia; Cell Adhesion Molecules; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Infarction, Middle Cerebral Artery; Leukocytes; Male; Neuroprotective Agents; Pioglitazone; Rats; Rats, Wistar; Regional Blood Flow; Reperfusion; Rosiglitazone; Stroke; Thiazolidinediones | 2010 |
Microdialysis combined blood sampling technique for the determination of rosiglitazone and glucose in brain and blood of gerbils subjected to cerebral ischemia.
Topics: Animals; Automation, Laboratory; Blood Glucose; Brain; Brain Infarction; Brain Ischemia; Gerbillinae; Glucose; Half-Life; Hypoglycemic Agents; Limit of Detection; Male; Microdialysis; PPAR gamma; Random Allocation; Reperfusion Injury; Reproducibility of Results; Rosiglitazone; Tandem Mass Spectrometry; Thiazolidinediones; Tissue Distribution | 2011 |
Anti-stroke profile of thiazolidin-4-one derivatives in focal cerebral ischemia model in rat.
Topics: Animals; Brain; Brain Ischemia; Excitatory Amino Acid Transporter 2; Glutamic Acid; Glutathione; Male; Neuroprotective Agents; PPAR gamma; Rats; Rats, Sprague-Dawley; Rosiglitazone; Thiazolidinediones | 2011 |
Neuroprotective efficacy of the peroxisome proliferator-activated receptor-γ ligand in chronic cerebral hypoperfusion.
Topics: Animals; Blotting, Western; Brain Ischemia; Immunohistochemistry; Ligands; Male; Maze Learning; Microglia; Neuroprotective Agents; PPAR gamma; Rats; Rats, Wistar; Rosiglitazone; S100 Proteins; Thiazolidinediones | 2011 |
Modulation of the oxidative stress and inflammatory response by PPAR-gamma agonists in the hippocampus of rats exposed to cerebral ischemia/reperfusion.
Topics: Animals; Brain Ischemia; Cyclooxygenase 2; Hippocampus; Inflammation; Injections, Intravenous; Lipid Peroxidation; Male; Mitogen-Activated Protein Kinases; NF-kappa B; Oxidative Stress; Pioglitazone; PPAR gamma; Rats; Rats, Wistar; Reperfusion Injury; Rosiglitazone; Signal Transduction; Thiazolidinediones | 2006 |
Neuroprotection against focal ischemic brain injury by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone.
Topics: Anilides; Animals; Animals, Newborn; Behavior, Animal; Blood Pressure; Body Temperature; Brain Ischemia; Cells, Cultured; Cerebral Infarction; Cytokines; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Gene Expression; Gene Expression Regulation; Granulocyte Colony-Stimulating Factor; Immunohistochemistry; Infarction, Middle Cerebral Artery; Intercellular Adhesion Molecule-1; Interleukin-3; Lectins; Lipopolysaccharides; Male; Mice; Mice, Inbred C57BL; Microglia; Neuroprotective Agents; Peroxidase; PPAR gamma; Psychomotor Performance; Recombinant Fusion Proteins; Recombinant Proteins; Reperfusion; Rosiglitazone; Thiazolidinediones | 2006 |